S&P 500   3,220.82 (+0.73%)
DOW   26,817.54 (+0.66%)
QQQ   259.19 (-0.45%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,220.82 (+0.73%)
DOW   26,817.54 (+0.66%)
QQQ   259.19 (-0.45%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,220.82 (+0.73%)
DOW   26,817.54 (+0.66%)
QQQ   259.19 (-0.45%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,220.82 (+0.73%)
DOW   26,817.54 (+0.66%)
QQQ   259.19 (-0.45%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
Log in

LON:RWSRWS Share Price, Forecast & News

GBX 585
-8.00 (-1.35 %)
(As of 07/15/2020 10:52 AM ET)
Add
Compare
Today's Range
585
Now: GBX 585
595.80
50-Day Range
569
MA: GBX 604.76
663
52-Week Range
399.71
Now: GBX 585
685
Volume274,615 shs
Average Volume265,149 shs
Market Capitalization£1.61 billion
P/E Ratio36.79
Dividend Yield1.46%
BetaN/A
RWS Holdings plc engages in the translation, intellectual property (IP) support, life sciences language, and localization businesses. The company operates through four segments: Patent Translation & Filing, Patent Information, Life Sciences, and Language Solutions. The Patent Translation & Filing segment undertakes patent translation and filing services of patent activities, as well as IP translations for litigation and information purposes, including prior-art documents, office actions, opposition proceedings and correspondence, and written opinions of international searching authorities. The Patent Information segment provides solutions to assist strategic decision-making across the intellectual property (IP) lifecycle. The Life Sciences segment offers a full suite of language services, including language solutions for clinical trial management; linguistic validation of clinical outcomes assessments; and regulatory affairs expertise, medical device documentation, and marketing and communications services, as well as e-learning and training programs for the life sciences industry. The Language Solutions segment provides translation and interpreting services in various sectors, such as automotive, chemical, defense, energy, engineering, finance, insurance, legal, and manufacturing sectors. This segment also offers terminology and professional services. It primarily operates in the United Kingdom, the United States, Continental Europe, Asia, and Australia. RWS Holdings plc was founded in 1958 and is headquartered in Chalfont St Peter, the United Kingdom.
Read More
RWS logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.6Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.96 out of 5 stars


Industry, Sector and Symbol

Industry Business Services
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone+44-1753-480200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£353.01 million
Cash FlowGBX 10.16 per share
Book ValueGBX 143.50 per share

Profitability

Miscellaneous

Employees2,459
Market Cap£1.61 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive RWS News and Ratings via Email

Sign-up to receive the latest news and ratings for RWS and its competitors with MarketBeat's FREE daily newsletter.

RWS (LON:RWS) Frequently Asked Questions

How has RWS's stock been impacted by COVID-19 (Coronavirus)?

RWS's stock was trading at GBX 500 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RWS shares have increased by 17.0% and is now trading at GBX 585. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of RWS?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RWS in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for RWS.

How were RWS's earnings last quarter?

RWS Holdings plc (LON:RWS) announced its quarterly earnings results on Tuesday, December, 11th. The company reported $17.40 EPS for the quarter, missing the Zacks' consensus estimate of $17.60 by $0.20. View RWS's earnings history.

How often does RWS pay dividends? What is the dividend yield for RWS?

RWS announced a dividend on Tuesday, June 9th. Stockholders of record on Thursday, June 25th will be paid a dividend of GBX 1.75 per share on Friday, July 17th. This represents a dividend yield of 0.29%. The ex-dividend date of this dividend is Thursday, June 25th. The official announcement can be seen at this link. View RWS's dividend history.

What price target have analysts set for RWS?

4 brokers have issued 1-year target prices for RWS's shares. Their forecasts range from GBX 530 to GBX 700. On average, they expect RWS's stock price to reach GBX 613.75 in the next twelve months. This suggests a possible upside of 4.9% from the stock's current price. View analysts' price targets for RWS.

Has RWS been receiving favorable news coverage?

News headlines about RWS stock have been trending somewhat positive on Wednesday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. RWS earned a news sentiment score of 2.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the near future. View the latest news about RWS.

Who are some of RWS's key competitors?

What other stocks do shareholders of RWS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RWS investors own include BioCryst Pharmaceuticals (BCRX), COCA COLA AMATI/ADR (CCLAY), Enbridge (ENB), IQE (IQEPF), RPC Group (RPC), Abbott Laboratories (ABT), Aldeyra Therapeutics (ALDX), Ares Capital (ARCC), ASOS (ASC) and ASML (ASML).

Who are RWS's key executives?

RWS's management team includes the following people:
  • Mr. Andrew Stephen Brode, Exec. Chairman (Age 79)
  • Mr. Richard J. Thompson, CEO & Exec. Director (Age 57)
  • Mr. Desmond Glass, CFO, Company Sec. & Director (Age 50)
  • Mr. Joe Lugo, Interim MD of Life Sciences & COO
  • Mr. Charles Sitch, Managing Director of IP Services

What is RWS's stock symbol?

RWS trades on the London Stock Exchange (LON) under the ticker symbol "RWS."

How do I buy shares of RWS?

Shares of RWS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is RWS's stock price today?

One share of RWS stock can currently be purchased for approximately GBX 585.

How big of a company is RWS?

RWS has a market capitalization of £1.61 billion and generates £353.01 million in revenue each year. RWS employs 2,459 workers across the globe.

What is RWS's official website?

The official website for RWS is www.rws.com.

How can I contact RWS?

RWS's mailing address is Europa House Chiltern Park, Chiltern Hill, GERRARDS CROSS, SL9 9FG, United Kingdom. The company can be reached via phone at +44-1753-480200.

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.